Bosun Asset Management’s AbbVie ABBV Stock Holding History

Bosun Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$901K	Sell	3,580 -81	-2%	-$17.4K	0.46%	30
2026 Q1	$796K	Hold	3,661	–	–	0.43%	33
2025 Q4	$836K	Sell	3,661 -139	-4%	-$31.7K	0.4%	31
2025 Q3	$880K	Sell	3,800 -117	-3%	-$23.8K	0.45%	22
2025 Q2	$727K	Sell	3,917 -331	-8%	-$61.5K	0.22%	109
2025 Q1	$890K	Buy	4,248 +20	+0.5%	+$3.89K	0.38%	64
2024 Q4	$751K	Sell	4,228 -202	-5%	-$37.1K	0.33%	87
2024 Q3	$875K	Buy	4,430 +199	+5%	+$37.1K	0.42%	67
2024 Q2	$726K	Buy	4,231 +403	+11%	+$66.8K	0.43%	60
2024 Q1	$697K	Sell	3,828 -4,683	-55%	-$807K	0.4%	78
2023 Q4	$1.32M	Sell	8,511 -198	-2%	-$28.9K	1.31%	18
2023 Q3	$1.3M	Sell	8,709 -298	-3%	-$43.7K	1.41%	15
2023 Q2	$1.21M	Buy	9,007 +700	+8%	+$103K	1.19%	15
2023 Q1	$1.32M	Buy	8,307 +3,300	+66%	+$505K	1.51%	9
2022 Q4	$809K	Sell	5,007 -100	-2%	-$15.3K	1.15%	15
2022 Q3	$685K	Buy	5,107 +1,500	+42%	+$215K	1.06%	17
2022 Q2	$552K	Sell	3,607 -5	-0.1%	-$764	0.76%	29
2022 Q1	$585K	Hold	3,612	–	–	0.61%	31
2021 Q4	$489K	Buy	+3,612	New	+$427K	0.44%	34

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bosun Asset Management's ABBV Position: Q2 2026 in Review

Bosun Asset Management reduced its AbbVie (ABBV) stake by 2.2% in Q2 2026, selling an estimated $17.4K and leaving 3,580 shares worth $901K. The position accounts for 0.46% of the portfolio, ranked #30.

Bosun Asset Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.32M in Q1 2023. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Bosun Asset Management held 3,580 shares of AbbVie worth $901K as of Q2 2026.
Bosun Asset Management sold 81 AbbVie shares in Q2 2026, an estimated $17.4K.
AbbVie made up 0.46% of Bosun Asset Management's portfolio in Q2 2026, its #30 holding.
Bosun Asset Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
Bosun Asset Management's AbbVie position peaked at $1.32M in Q1 2023.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bosun Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.